Year: 2026

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) is pleased to provide an update on the advancement of its 100% owned Eskay Creek Gold-Silver Project (“Eskay” or the “Project”) in Northwest British Columbia. Since commencing development activities in December 2024, the Company has achieved notable progress advancing Eskay Creek. As of February 28, 2026, the Project was 49% complete, with 66% of total project costs now contractually committed. Initial production at Eskay Creek remains on schedule, targeted for the second quarter of 2027 and commercial production expected in the third quarter. Randy Reichert, President & Chief Executive Officer of Skeena, commented, “Our strategy of initiating development activities...

RENO, Nev., March 31, 2026 (GLOBE NEWSWIRE) — Ormat Technologies Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company, today announced that it plans to publish its first quarter financial results in a press release that will be issued on Wednesday, May 6, 2026, after the market closes. In conjunction with this report, the Company has scheduled a conference call to discuss the results at 09:00 a.m. ET on Thursday May 7, 2026. Participants within the United States and Canada, please dial 1-800-715-9871, approximately 15 minutes prior to the scheduled start of the call. If you are calling from outside the United States or Canada, please dial +1-646-307-1963. The access code for the call is 3818407. Please request the “Ormat Technologies, Inc. call” when prompted by the conference call operator....

Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2026 American Association for Cancer Research Meeting (2026 AACR), taking place from April 17th to April 22nd in San Diego, CA.Abstract Title Poster Presentation DetailsNXP900, a Phase 1b, first-in-class YES1/SRC inhibitor demonstrates potent synergy with KRAS inhibitors in KRASi sensitive and resistant NSCLC models Session TitleCombination Targeted Therapy Session Date / TimeApril 21st, 2:00 PM – 5:00 PM PTResistance to the SFK inhibitor NXP900...

                               ANNUAL GENERAL MEETING OF PARK STREET A/SIn accordance with article 6.2 of the articles of association, the annual general meeting of Park Street A/S (the “Company”) is hereby called to be held on28 April 2026, at 2:00 p.m. (Danish time)The general meeting will be held at the Company’s addressAmaliegade 6, 2 tv, 1256 København KAGENDAThe board of directors has prepared the following agenda:Board of directors’ report on the Company’s activities in the past year.Presentation and approval of the audited annual report.Board of directors’ proposed resolution on the appropriation of profit or covering of loss according to the approved annual report.Presentation of and advisory vote of the remuneration report.Authorisation to acquire treasury...

Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight Watchers’ integrated care platform NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for Wegovy® that significantly reduces out-of-pocket costs and is a result of expanded collaboration between Weight Watchers and Novo Nordisk. The new subscription offer gives Weight Watchers Med+ members access to the lowest available self-pay price in the market for doses of Wegovy not otherwise available through limited-time offers, saving cash-pay members...

Park Street A/S – Annual Report 2025 Copenhagen, 31 March 2026 Park Street primarily uses EBVAT (Earnings before value adjustments and tax) as the key measure of the Group’s operating performance. The Group achieved an EBVAT of DKK 11.5 million in 2025 (2024: DKK 2.8 million), compared to previously communicated expectations of DKK 20–25 million. The variance is attributable to a combination of factors, primarily weaker than expected performance from hotel operations and the newly launched co-working site in Odense, as well as a reduced asset base following property disposal during the year. During 2025, the Group undertook several significant initiatives, including refinancing activities, operational optimisation and capex-led leasing initiatives. While some of these actions impacted short-term earnings, they are expected to deliver sustained...